Business Context and Reporting Period
Company: Achieve Life Sciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: April 27, 2020 (Event Date)
Reporting Period: Specific event reporting for a private placement offering executed on April 27 and April 28, 2020.
Key Financial Metrics
This filing details a capital raise rather than operational financial results. Key metrics include:
- Gross Proceeds: Approximately $1,853,165.
- Net Proceeds: Approximately $1.6 million (after deducting broker commissions, expenses, and estimated offering costs).
- Units Sold: Approximately 5,615,653 units.
- Offering Price: $0.33 per Unit.
- Unit Composition: One share of Common Stock and one warrant to purchase 0.75 shares of Common Stock.
- Broker Commission: 9% of gross proceeds paid in cash plus a broker warrant.
Material Changes
The primary material change is the entry into definitive agreements for a private placement of equity securities. This transaction increases the company's share count and outstanding warrants. The filing does not provide comparative financial data (e.g., revenue or profit changes) against prior periods as it is an event-driven report.
Guidance, Outlook, and Risks
Management Commentary: The company utilized the proceeds to fund operations, though specific allocation details are not provided in this text. A press release dated April 30, 2020, was issued to announce the offering.
Warrant Terms and Risks:
- Exercise Dates: Warrants are exercisable starting October 27, 2020 (6 months post-closing) and expire 5 years after the initial closing.
- Exercise Prices: $0.362 for warrants issued April 27; $0.366 for warrants issued April 28.
- Call Provision: The Company may call for cancellation of warrants if the volume-weighted average price exceeds 300% of the exercise price for 30 consecutive trading days, subject to volume and beneficial ownership conditions.
- Registration Rights: The Company must file a registration statement within 60 days of the final closing to register the resale of the securities.
Investor Verification Checklist
- Verify the final closing date of the offering to confirm the exact 60-day deadline for the registration statement filing.
- Review the attached exhibits (4.1, 10.1, 10.2, 10.3) for full legal terms regarding warrant adjustments and call provisions.
- Confirm the actual net proceeds received after all offering expenses are finalized.
- Monitor the company's stock price relative to the warrant exercise prices ($0.362/$0.366) to assess potential dilution or warrant call scenarios.